Literature DB >> 20083154

Genetics and phenomics of hypothyroidism due to TSH resistance.

Luca Persani1, Davide Calebiro, Daniela Cordella, Giovanna Weber, Giulia Gelmini, Domenico Libri, Tiziana de Filippis, Marco Bonomi.   

Abstract

The resistance to thyrotropin (TSH) action is the disease associated with molecular defects hampering the adequate transmission of TSH stimulatory signal into thyroid cells. The defect may in principle affect every step along the cascade of events following the binding of TSH to its receptor (TSHR) on thyroid cell membranes. After the description of the first family affected with loss-of-function (LOF) TSHR mutations in 1995, there is now evidence that TSH resistance is a disease with a broad range of expressivity going from severe congenital hypothyroidism (CH) with thyroid hypoplasia to mild hyperthyrotropinemia (hyperTSH) associated with an apparent euthyroid state. More severe forms occur in patients with disrupting biallelic TSHR mutations and follow a recessive pattern of inheritance. Differential diagnosis in these cases includes the exclusion of other causes of thyroid dysgenesis, such as mutations in thyroid transcription factors. More mild forms may instead occur in patients with monoallelic TSHR defects following a dominant mode of inheritance. In these cases we described the dominant negative effect exerted by some LOF mutants on the activity of the wild-type TSHR. Differential diagnosis involves the exclusion of mild hypothyroidism in autoimmune thyroid disease or pseudohypoparathyroidism associated with genetic or epigenetic defects at the GNAS locus. This review will focus on the prevalence of TSHR mutations, on the molecular mechanisms leading to TSH resistance and on the variable clinical expression of this disease. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20083154     DOI: 10.1016/j.mce.2010.01.008

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  30 in total

1.  Consecutive mutational events in a TSHR allele of Arab families with resistance to thyroid stimulating hormone.

Authors:  Chutintorn Sriphrapradang; Alina German; Alexandra M Dumitrescu; Samuel Refetoff
Journal:  Thyroid       Date:  2012-02-07       Impact factor: 6.568

Review 2.  Role and Mechanisms of Actions of Thyroid Hormone on the Skeletal Development.

Authors:  Ha-Young Kim; Subburaman Mohan
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

Review 3.  Thyrotropin isoforms: implications for thyrotropin analysis and clinical practice.

Authors:  Joshua M Estrada; Danielle Soldin; Timothy M Buckey; Kenneth D Burman; Offie P Soldin
Journal:  Thyroid       Date:  2013-12-13       Impact factor: 6.568

4.  Thyroid gland: TSHR mutations and subclinical congenital hypothyroidism.

Authors:  Nadia Schoenmakers; V Krishna Chatterjee
Journal:  Nat Rev Endocrinol       Date:  2015-02-24       Impact factor: 43.330

Review 5.  Subclinical hypothyroidism in childhood - current knowledge and open issues.

Authors:  Mariacarolina Salerno; Donatella Capalbo; Manuela Cerbone; Filippo De Luca
Journal:  Nat Rev Endocrinol       Date:  2016-07-01       Impact factor: 43.330

6.  Identification and functional characterization of a novel thyrotropin receptor mutation (V87L) in a Chinese woman with subclinical hypothyroidism.

Authors:  Hong-Mei Zhang; Ya-Qin Zhou; Yan Dong; Qing Su
Journal:  Exp Ther Med       Date:  2016-12-06       Impact factor: 2.447

Review 7.  Heterogeneous phenotype in children affected by non-autoimmune hypothyroidism: an update.

Authors:  M C Vigone; M Di Frenna; G Weber
Journal:  J Endocrinol Invest       Date:  2015-04-28       Impact factor: 4.256

Review 8.  Genetic defects of hydrogen peroxide generation in the thyroid gland.

Authors:  G Weber; S Rabbiosi; I Zamproni; L Fugazzola
Journal:  J Endocrinol Invest       Date:  2013-02-12       Impact factor: 4.256

Review 9.  The Italian screening program for primary congenital hypothyroidism: actions to improve screening, diagnosis, follow-up, and surveillance.

Authors:  A Cassio; C Corbetta; I Antonozzi; F Calaciura; U Caruso; G Cesaretti; R Gastaldi; E Medda; F Mosca; E Pasquini; M C Salerno; V Stoppioni; M Tonacchera; G Weber; A Olivieri
Journal:  J Endocrinol Invest       Date:  2013-02-12       Impact factor: 4.256

10.  Frequency and effect on serum TSH of phosphodiesterase 8B (PDE8B) gene polymorphisms in patients with sporadic nonautoimmune subclinical hypothyroidism.

Authors:  P Agretti; G De Marco; C Di Cosmo; B Bagattini; E Ferrarini; L Montanelli; P Vitti; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.